venous-thromboembolism

Documents about venous-thromboembolism

• Decision Aid for Anticoagulation Duration After Unprovoked Venous Thromboembolism#847210ClinicalTrials.gov
• Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Total Hip Replacement Surgery#901123ClinicalTrials.gov
• Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in Pregnancy#1029956ClinicalTrials.gov
• Prevention of Venous and Arterial Thromboembolism, in Cancer Patients Undergoing Chemotherapy, With a Low Molecular Weight Heparin (Nadroparin Calcium)#836225ClinicalTrials.gov
• Impact of COVID-19 Vaccines on Cerebrovascular Health#916525ClinicalTrials.gov
• Study to Evaluate the Safety and Efficacy of Pradaxar for the Prevention of Venous Thromboembolism in the Mexican Population Undergoing Elective Total Hip or Knee Replacement Surgery#1009665ClinicalTrials.gov
• An Observational Study On The Safety And Tolerability Of Prolonged Thrombosis Prophylaxis With Fragmin®#834370ClinicalTrials.gov
• Dose Ranging Study in Elective Total Hip Replacement Surgery#850293ClinicalTrials.gov
• Celect Vena Cava Filter Clinical Trial#852103ClinicalTrials.gov
• Sickle Cell Trait and the Risk of Venous Thromboembolism#911029ClinicalTrials.gov
• Evaluation of the Use of Apixaban in Prevnetion of Thromboembolic Disease in Patients With Myeloma Trated With iMiDs#875194ClinicalTrials.gov
• Electronic Strategies to Enhance Venous Thromboemboli (VTE) Prophylaxis in Hospitalized Medical Patients#1008150ClinicalTrials.gov
• Lower Limb Blood Flow Geko vs Foot Pump#905196ClinicalTrials.gov
• Cleaner Long-tErm Assessment Registry - Venous Insights and Efficacy With eXtended Tracking#879353ClinicalTrials.gov
• LIFE - Lung Cancer, Immunotherapy, Frailty, Effect#146440ClinicalTrials.gov
• Factors Influencing Physician Adherence to Venous Thromboembolism Risk Assessment Model Recommendations: A Best-Worst Scaling.#275497NCBI PubMed Central
• Exploring primary care providers' perspectives on clinical decision support for venous thromboembolism diagnosis: a qualitative study.#670920NCBI PubMed Central
• Thromboembolic and Hemorrhagic Complications of Anticoagulant Treatment in Patients With CAT#801846ClinicalTrials.gov
• Rivaroxaban as Thrombosis Prophylaxis in Bariatric Surgery#966467ClinicalTrials.gov
• Association of Anti-factor Xa Activity With Venous Thromboembolism in Critically Ill Patients#968460ClinicalTrials.gov
• Safety and Efficacy Study of Fitaya Vena Cava Filter#992648ClinicalTrials.gov
• Cisplatin-Based Chemotherapy Is a Strong Risk Factor for Thromboembolic Events in Small-Cell Lung Cancer#450642S-Space: Seoul National University
• DOCE Study Interaction Between Direct Oral Anticoagulants and Drug-metabolizing Enzyme Inducers#845681ClinicalTrials.gov
• Tolerability , PK/PD and Safety of Dabigatran Etexilate Oral Liquid Formulation in Children < 1 Year of Age#850378ClinicalTrials.gov
• People's Hospital of Xinjiang Uygur Autonomous Region#880381ClinicalTrials.gov
• A Performance Evaluation of the LumiraDx Point Of Care D-dimer Assay#1046602ClinicalTrials.gov
• Increased Risk of VTE and Higher Hypercoagulability in Patients Recovered in ICU and in Medical Ward for COVID-19#914246ClinicalTrials.gov
• Cardiovascular Complications and COVID-19 (CovCardioVasc-Study)#123587ClinicalTrials.gov
• Weight-Based Enoxaparin Dosing and Real-Time Dose Adjustment in Orthopaedic Trauma#837973ClinicalTrials.gov
• Implementing Prescriber-Pharmacist Collaborative Care for Evidence-based Anticoagulant Use#837975ClinicalTrials.gov
• Factor XI inhibiTion for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty#845267ClinicalTrials.gov
• Rivaroxaban for the Prevention of Venous Thromboembolism in Asian Patients With Cancer#868796ClinicalTrials.gov
• Edoxaban Management in Diagnostic and Therapeutic Procedures#881366ClinicalTrials.gov
• A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE#1009685ClinicalTrials.gov
• Study to Evaluate Safety, PK and PD of Single and Multiple Ascending Doses of EP-7041 in Healthy Subjects#877787ClinicalTrials.gov
• Direct Oral Factor-Xa Inhibitors in Patients with Acute Venous Thromboembolism and Renal Impairment. A randomized controlled trial.#640140bioRxiv / medRxiv
• Evaluation of Anti-Xa Levels in Surgery Patients Receiving Weight-based Heparin#827903ClinicalTrials.gov
• PREVAIL: PREvention of VTE After Acute Ischemic Stroke With LMWH Enoxaparin ( - VTE: Venous Thromboembolism - LMWH: Low Molecular Weight Heparin)#843767ClinicalTrials.gov
• CLEANer Aspiration for Pulmonary Embolism#852487ClinicalTrials.gov
• Cancer Associated Thrombosis, a Pilot Treatment Study Using Rivaroxaban#858586ClinicalTrials.gov
• Epidemiology of Thromboembolism Disease: A Cohort Study#876756ClinicalTrials.gov
• PROSPER: PostpaRtum PrOphylaxiS for PE Randomized Control Trial Pilot#907312ClinicalTrials.gov
• Multisite Real-World Validation of an Electronic Health Record-Integrated Generative Artificial Intelligence Tool for Venous Thromboembolism Risk Stratification#387032bioRxiv / medRxiv
• Risk of Venous Thromboembolism in Patients Receiving First-Line Chemotherapy for Disseminated Germ Cell Tumours#837307ClinicalTrials.gov
• Observatory of Invasive Procedures and Bleeding in Patients Treated With New Oral Anticoagulants#854875ClinicalTrials.gov
• Improving Anticoagulation Control in VISN 1#891220ClinicalTrials.gov
• Pulmonary Embolism as a Cause of COPD Exacerbations#907398ClinicalTrials.gov
• Explore the Causal Effect of SGLT2 Inhibition on Venous Thromboembolism Events: A Drug-Target Mendelian Randomization Study With Pharmacovigilance Analysis.#242228NCBI PubMed Central
• Cannabis Use and the Risk of Incident Venous Thromboembolism Among People With HIV: A Longitudinal Cohort Study in the United States.#242312NCBI PubMed Central
• Factors Influencing Physician Adherence to Venous Thromboembolism Risk Assessment Model Recommendations: A Best–Worst Scaling#299167Springer Nature OA